In the race to vaccinate the world against COVID-19, developing countries are running dangerously behind as mutations of the virus make it harder to catch up—a situation that could spell at least another year of humanitarian and economic misery for poor nations.
Wall Street Journal: Vaccine delays in developing nations risk prolonging pandemic
View of vials on a production line at the factory of British multinational pharmaceutical company GlaxoSmithKline (GSK) in Saint-Amand-les-Eaux, northern France, on Dec. 3, 2020, where the adjuvant for Covid-19 vaccines will be manufactured.
